Sarah Ellinwood, Ph.D. Joins Workforce Genetics as Managing Editor for BioBuzz Media

Headshot of Sarah Ellinwood
Published on :

Sarah Ellinwood, Ph.D. Joins Workforce Genetics as Managing Editor for BioBuzz Media Workforce Genetics welcomes molecular biologist Sarah Ellinwood, Ph.D., as its new Managing Editor. Sarah will be collaborating closely [….]

5 Questions With Sandy Williams, Ph.D., President and Founder of Access Biomedical Solutions

Headshot of Sandy Williams
Published on :

Sandy is the President and Founder of Access Biomedical Solutions, a consultancy launched in 2015 that is focused on empowering biotech and medtech companies grow and accomplish their goals. She achieves this by combining her technical expertise and marketing skills to quickly identify a company’s current trajectory, what success looks like for them, and what their biggest gaps are.

Erik Crown Joins Workforce Genetics & BioBuzz to Lead Marketing & Communications

Published on :

Workforce Genetics welcomes Erik Crown as the new Head of Marketing and Communications to be the head storyteller conveying the vision for both the Talent and BioBuzz Media divisions which offer a variety of services to life science employers across several functional areas.

Children’s National’s Dr. Kurt Newman Named WBJ’s 2021 CEO of the Year

Published on :

Our CEO of the Year stood at the nexus of all of those issues, on the literal front lines of the health crisis amid a financial downturn and worker shortage. He was working to not only sustain, but also grow, his organization, even as he assumed responsibility for attending to our community’s most vulnerable population: our children.
He is Dr. Kurt Newman, president and CEO of Children’s National Hospital.

5 Questions With Julie Lenzer, Chief Innovation Officer, University of Maryland

Published on :

A serial entrepreneur and ecosystem builder, Julie Lenzer is currently the Chief Innovation Officer at the University of Maryland and Founding Director for the newly-launched Quantum Startup Foundry. In these roles, she is charged with fostering and deploying innovation to drive economic and social impact from both university-affiliated and community-based innovators and oversees the university’s tech transfer office, the Maryland Small Business Development Center (SBDC), the Veteran’s Business Outreach Center (VBOC), the Mixed/Augmented/Virtual Reality Innovation Center (MAVRIC), as well as university engagement with the Discovery District (UMD’s 150-acre research park). An active angel investor, she is also on the investment committee of the $10M Maryland Momentum Fund and UMD’s newly-launched Discovery Fund.

In Conversation: John Mumm, Chief Executive Officer, Deka Biosciences

Published on :

John Mumm is a serial biotechnology entrepreneur who, as a young researcher, demonstrated the importance of the cytokine, interleukin -10 (IL-10), in activating the immune system to destroy tumors. That research led to the use of Pegylated IL-10 to treat patients with pancreatic cancer and other solid tumors through his work at ARMO Biosciences, a company he founded and was later acquired by Eli Lilly in 2018.

5 Questions With Priscilla Fussell, Ph.D., J.D., Associate at McBee, Moore & Vanik IP, LLC

Published on :

Dr. Fussell represents a diverse array of clients in various intellectual property matters, including patent and trademark prosecution and litigation. She performs due diligence, freedom-to-operate, validity, and patentability analyses in the chemical and life sciences industries. She has a wide range of experience in the biotechnology, pharmaceutical, and chemical arts, including medical devices, biofuels, probiotics, plants, herbicides, fertilizers, seeds, nucleic acids, proteins, enzymes, carbohydrates, diagnostics, methods of treating cancer, cancer diagnostics, and agents for treating cancer. Dr. Fussell has negotiated and drafted a wide variety of agreements relating to intellectual property interests, including settlement agreements.

TEDCO’s Tammi Thomas Selected for Leadership Greater Washington 2022 Cohort

Published on :

TEDCO’s Tammi Thomas Selected for Leadership Greater Washington 2022 Cohort. Established over 35 years ago, LGW has developed nearly 2,000 executive-level leaders from the District of Columbia, Virginia, and Suburban Maryland through its flagship offering, the Signature Program. It’s an intensive ten-month program that exposes professionals to regional civic issues through education, connection, and knowledge sharing. With the purpose to leverage collective knowledge and resources to make the Greater Washington region a more dynamic and collaborative community. 

5 Questions with Eric A. Stahlberg, PhD, Director Bioinformatics and Data Science, Frederick National Laboratory for Cancer Research

Published on :

Dr. Eric Stahlberg is director of Biomedical Informatics and Data Science at the Frederick National Laboratory for Cancer Research (FNL). Stahlberg has been instrumental in establishing FNL’s high-performance computing initiative and in assembling scientific teams across multiple, complex organizations to advance predictive oncology.

Adaptive Phage Therapeutics Appoints Michele Wales, Ph.D., J.D., as Chief Legal Officer

Dr. Wales joins APT with extensive experience in litigation and intellectual property law, specifically within the life sciences industry.
Published on :

Adaptive Phage Therapeutics, Inc., a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that it has appointed Michele Wales, Ph.D., J.D., as Chief Legal Officer. Dr. Wales joins APT with extensive experience in litigation and intellectual property law, specifically within the life sciences industry.